NCT06988787 Multifaceted Intervention to Restore Resilience and Overcome Risk
| NCT ID | NCT06988787 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Condition | Military Sexual Trauma |
| Study Type | INTERVENTIONAL |
| Enrollment | 136 participants |
| Start Date | 2025-09-12 |
| Primary Completion | 2028-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 136 participants in total. It began in 2025-09-12 with a primary completion date of 2028-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The MIRROR study will compare the effectiveness of two interventions in improving emotion regulation and reducing PTSD symptoms in female Veterans with military sexual trauma (MST) and/or intimate partner violence (IPV) and co-occurring brain injury.
Eligibility Criteria
Inclusion Criteria: * Able to consent as determined by UBACC, are English-speaking FVets who are 18+ years old * Screen positive for exposure to IPV and/or MST using the VA Intimate Partner Violence Assistance Program (VA IPVAP) and MST Screening Protocol, * Have a history of at least one BI assessed using the BISQ+IPV, * Sub-threshold PTSD (operationalized as a total score of \>33 on the PTSD Checklist Diagnostic and Statistical Manual of Mental Disorders-5 (PCL-5), * Report deficits in Emotion Regulation (operationalized as a score of 0.5 SD above published means on the DERS). Exclusion Criteria: * FVets at high risk for suicide (respond yes to items 3, 4, 5, or 8 on the Columbia Suicide Severity Rating Scale \[C-SSRS\]), * Observable active psychosis (e.g., auditory hallucinations, grandiose delusions), * Those determined to have problematic substance use (score \> 27 on the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) will be referred to substance use dependence programs for concurrent treatment. The PI and Co-Is will collaborate with the substance use dependence program to determine continued participation.
Contact & Investigator
Maria Kajankova, PhD
PRINCIPAL INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Frequently Asked Questions
Who can join the NCT06988787 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Military Sexual Trauma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06988787 currently recruiting?
Yes, NCT06988787 is actively recruiting participants. Contact the research team at maria.kajankova@mountsinai.org for enrollment information.
Where is the NCT06988787 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06988787 clinical trial?
NCT06988787 is sponsored by Icahn School of Medicine at Mount Sinai. The principal investigator is Maria Kajankova, PhD at Icahn School of Medicine at Mount Sinai. The trial plans to enroll 136 participants.